A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/28/2002	WO2002094241A1 Delivery of compounds for the treatment of migraine through an inhalation route
11/28/2002	WO2002094240A1 Delivery of physiologically active compounds through an inhalation route
11/28/2002	WO2002094239A1 Delivery of diphenhydramine through an inhalation route
11/28/2002	WO2002094238A1 Delivery of anti-migraine compounds through an inhalation route
11/28/2002	WO2002094237A1 Delivery of beta-blockers through an inhalation route
11/28/2002	WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002	WO2002094235A1 Delivery of compounds for the treatment of parkinsons through an inhalation route
11/28/2002	WO2002094234A1 Delivery of opioids through an inhalation route
11/28/2002	WO2002094233A1 Delivery of antiemetics through an inhalation route
11/28/2002	WO2002094232A1 Delivery of antidepressants through an inhalation route
11/28/2002	WO2002094231A1 Delivery of analgesics through an inhalation route
11/28/2002	WO2002094230A1 Delivery of sedative-hypnotics trough an inhalation route
11/28/2002	WO2002094229A1 Delivery of muscle relaxants through an inhalation route
11/28/2002	WO2002094227A1 Controlled release drug delivery device
11/28/2002	WO2002094225A1 Granular preparations of gaboxadol
11/28/2002	WO2002094220A1 Liquid pharmaceutical composition
11/28/2002	WO2002094219A2 Delivery of erectile dysfunction drugs through an inhalation route
11/28/2002	WO2002094218A2 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
11/28/2002	WO2002094217A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	WO2002094216A2 Delivery of stimulants through an inhalation route
11/28/2002	WO2002094215A2 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vimyl acetate as surface stabilizers
11/28/2002	WO2002094211A1 Cosmetic or dermatological preparations containing one or more ketohexoses
11/28/2002	WO2002094210A2 Cosmetic agents
11/28/2002	WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094196A2 Method of treatment for cancers associated with elevated
11/28/2002	WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002	WO2002094189A2 Compositions and methods for treating or preventing convulsions or seizures
11/28/2002	WO2002094188A2 Methods for regulating bacteria
11/28/2002	WO2002094187A2 Novel use
11/28/2002	WO2002094186A2 Urazole compounds useful as anti-inflammatory agents
11/28/2002	WO2002094185A2 Conjugates and compositions for cellular delivery
11/28/2002	WO2002094183A2 A method for tumor treatment with fumagillol derivatives
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002094179A2 Novel topical microbicidal compositions
11/28/2002	WO2002094178A2 Treatment of renal fibrosis
11/28/2002	WO2002094176A2 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments
11/28/2002	WO2002094021A1 A combination and method of treatment of cancer utilizing a cox-2 inhibitor and an hmg-coa inhibitor and cystine to enhance glutathione
11/28/2002	WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002	WO2002094018A1 Compositions comprising d-chiro inositol and lipid lowering compounds and methods of treatment thereof
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002085377A8 Method for lowering serum glucose
11/28/2002	WO2002081651A3 Polyphenolics for enhancing endothelial cell-mediated fibrinolysis
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002080859A3 Inhalation drug combinations
11/28/2002	WO2002078745A3 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
11/28/2002	WO2002078641A3 Pyrrolidine sulfonamides
11/28/2002	WO2002078629A3 Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
11/28/2002	WO2002078616A3 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
11/28/2002	WO2002076440A3 Methods of treating alzheimer's disease with piperidin derivates
11/28/2002	WO2002073235A3 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
11/28/2002	WO2002072080A3 Paracetamol solutions which are stable in storage and ready for infusion
11/28/2002	WO2002072039A3 Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002070532A3 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
11/28/2002	WO2002064557A9 New crystal forms of oxcarbazepine and processes for their preparation
11/28/2002	WO2002062777A3 Amino ceramide-like compounds and therapeutic methods of use
11/28/2002	WO2002062322A3 Glycine betaine and its use as anti-hemorrhagic agent
11/28/2002	WO2002058683A3 Carotenoids as anti-hypertension agents
11/28/2002	WO2002057790A3 Methods and compositions for diagnosing and treating a subject having depression
11/28/2002	WO2002057273A9 Serine protease inhibitors comprising a hydrogen-bond acceptor
11/28/2002	WO2002048106A3 Isoindolin-1-one glucokinase activators
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002039997A3 Ace-2 modulating compounds and use thereof
11/28/2002	WO2002036601A3 Phase transfer catalyzed glycosidation of an indolocarbazole
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002020002A3 A method for treating allergies
11/28/2002	WO2002011702A3 Hydrogel-driven drug dosage form
11/28/2002	WO2002009759A3 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001096329A1 Medicinal compositions containing propenone derivatives
11/28/2002	WO2001092219A1 Glycinamides
11/28/2002	WO2001092214A1 Carbamic acid esters as inhibitors of factor xa
11/28/2002	WO2001091587A9 Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain
11/28/2002	WO2001090345A3 Methods and compositions for enhancing the delivery of a nucleic acid to a cell
11/28/2002	WO2001089542A3 Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
11/28/2002	WO2001089497A3 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
11/28/2002	WO2001082897A3 Liposome drug delivery
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001068911A3 Diagnosis of diseases associated with the cell cycle
11/28/2002	WO2001049277A3 Immune response modulation
11/28/2002	WO2001047468A3 Association of deoxyfructosazine and an antidiabetic inhibiting alpha-glucosidase
11/28/2002	WO2001035942A9 Analgesic compositions containing buprenorphine
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178458 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a target
11/28/2002	US20020177839 Microprojection array having a beneficial agent containing coating
11/28/2002	US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders
11/28/2002	US20020177722 Method for the preparation of citalopram
11/28/2002	US20020177717 Compounds and methods for the inhibition of the expression of VCAM-1
11/28/2002	US20020177716 Intermediates of CETP inhibitors
11/28/2002	US20020177714 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/28/2002	US20020177707 Aminoaryl oxazolidinone n-oxides
11/28/2002	US20020177706 Rheumatic diseases; antiarthritic agents; antitumor agents
11/28/2002	US20020177703 Novel crystalline forms of an antiviral benzimidazole compound
11/28/2002	US20020177689 Compounds for the treatment of sexual dysfunction
11/28/2002	US20020177626 Comprises analgesics such as ibuprofen and diphenhydramine; storage stability
11/28/2002	US20020177625 Class of glaucoma drugs to enhance aqueous humor outflow and lower intra-ocular pressure
11/28/2002	US20020177624 Prevents vaginitis
11/28/2002	US20020177623 Use of (Z) -2-cyano-3-hydroxy-but-2-enoic acid-(4' -trifluoromethylphenyl)-amide for treating multiple sclerosis
11/28/2002	US20020177622 Neuroprotectants; enhancing cognition

1 ... 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 5653 5654 5655 5656 ... 7860